Application 205755

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZYKADIACERITINIBCAPSULE;ORAL150MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0640ZYKADIAceritinibNovartis Pharmaceuticals NDACurrent
0078-0640ZYKADIAceritinibNovartis Pharmaceuticals CorporationNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
68978SUPPL2021-10-13
68953SUPPL2021-10-12
68446SUPPL2021-08-24
68436SUPPL2021-08-22
57916SUPPL2019-03-14
57923SUPPL2019-03-07
50928SUPPL2017-12-27
50855SUPPL2017-12-26
50493SUPPL2017-11-27
50468SUPPL2017-11-21
49036SUPPL2017-07-21
49028SUPPL2017-07-20
48638SUPPL2017-06-02
48601SUPPL2017-05-31
45256SUPPL2016-09-09
45271SUPPL2016-09-08
40500SUPPL2015-07-24
19681SUPPL2015-07-24
32716SUPPL2015-07-23
10495SUPPL2015-07-23
43502ORIG2014-05-16
24503ORIG2014-05-16
32715ORIG2014-04-30
19680ORIG2014-04-29